Stryker (SYK) Cash & Current Investments (2009 - 2026)
Stryker (SYK) posted quarterly Cash & Current Investments of $3.5 billion for Q2 2026, up 41.07% year-over-year from $2.5 billion in Q2 2025, and up 17.23% on a QoQ basis from $3.0 billion in Q1 2026.
Stryker (SYK) Cash & Current Investments (2009 - 2026) Analysis & Trends
Stryker has reported Cash & Current Investments for 18 years, with the latest figure at $3.5 billion in Q2 2026.
- Cash & Current Investments for Q2 2026 came in at $3.5 billion, up 41.07% year-over-year; the trailing twelve-month figure through Jun 2026 was $3.5 billion (up 41.07% YoY), and the FY2025 annual result was $4.1 billion, down 6.86% from the prior year.
- Cash & Current Investments grew to $3.5 billion in Q2 2026, from $3.0 billion in the prior quarter.
- Over five years, Cash & Current Investments peaked at $4.6 billion in Q3 2024 and troughed at $1.1 billion in Q2 2022.
- A 5-year average of $2.6 billion and a median of $2.4 billion in 2024 frame the typical range for Cash & Current Investments.
- The widest annual swing landed in 2022, when Cash & Current Investments tumbled 51.53%; it then soared 137.6% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $1.9 billion in 2022, then soared by 58.35% to $3.1 billion in 2023, then soared by 44.19% to $4.4 billion in 2024, then decreased by 6.86% to $4.1 billion in 2025, then decreased by 15.22% to $3.5 billion in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $3.5 billion in Q2 2026, $3.0 billion in Q1 2026, and $4.1 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 410.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.48 Bn |
| Mar 31, 2026 | 2.88 Bn |
| Dec 31, 2025 | 4.10 Bn |
| Sep 30, 2025 | 3.34 Bn |
| Jun 30, 2025 | 2.38 Bn |
| Mar 31, 2025 | 2.32 Bn |
| Dec 31, 2024 | 3.74 Bn |
| Sep 30, 2024 | 4.60 Bn |
| Jun 30, 2024 | 1.96 Bn |
| Mar 31, 2024 | 2.41 Bn |
| Dec 31, 2023 | 3.05 Bn |
| Sep 30, 2023 | 1.94 Bn |
| Jun 30, 2023 | 1.48 Bn |
| Mar 31, 2023 | 1.76 Bn |
| Dec 31, 2022 | 1.93 Bn |
| Sep 30, 2022 | 1.50 Bn |
| Jun 30, 2022 | 1.13 Bn |
| Mar 31, 2022 | 1.53 Bn |
| Dec 31, 2021 | 3.02 Bn |
| Sep 30, 2021 | 2.64 Bn |